Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international study

P. F. Castellotti, V. Rossetti, S. Aliberti, P. Tarsia, P. Peyrani, F. Blasi, J. Ramirez (Milan, Italy; Louisville, KY, United States Of America)

Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Session: Treatment and outcome in hospitalised patients with community-acquired pneumonia
Session type: E-Communication Session
Number: 1846
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. F. Castellotti, V. Rossetti, S. Aliberti, P. Tarsia, P. Peyrani, F. Blasi, J. Ramirez (Milan, Italy; Louisville, KY, United States Of America). Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international study. Eur Respir J 2008; 32: Suppl. 52, 1846

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008


Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005

Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007

Commutity acquired pneumonia scores utility. PSI (FINE) vs BTSm (CURB)
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005


Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Prognostic value of the pneumonia severity index (PSI), CURB-65 for young and elderly patients
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Comparison of PSI, A-DROP, CURB-65, CRB-65, and SOAR indices in hospitalized patients with community acquired pneumonia
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP)
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Inpatients with PSI III community-acquired pneumonia: are low or high risk patients?
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007



Incidence and etiology of early (E) and late (L) onset ventilator-associated pneumonia (VAP) in a university hospital
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

The simplified acute physiology score 3 (SAPS 3) predicts mortality in an intermediate care unit (iCU)
Source: Eur Respir J 2007; 30: Suppl. 51, 581s
Year: 2007

Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment; results from the German competence network CAPNETZ
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009

Apache II score and prediction of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009

Community-acquired pneumonia (CAP) in the elderly: Prediction of mortality by physical symptoms, laboratory values and radiographic features on admission
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010